Apremilast cream for plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This study tests a new cream form of the drug apremilast for mild plaque psoriasis that covers no more than 10% of your body. It aims to see if the cream is safe and works well for treating small patches of psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic plaque psoriasis that covers no more than 10% of your body surface area (roughly the size of ten palm-sized patches or less).
- You have not used any light therapy or pills for psoriasis in the last 12 weeks.
- You have not used any prescription creams for psoriasis in the last 4 weeks.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 3 months.
- You do not have serious kidney, liver, heart, blood, hormone, or immune system diseases, and you are not on medications that suppress your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called apremilast (brand name ApoLla) to see how well it works and how safe it is for people with moderate to severe psoriasis. If you have had psoriasis for 6 months or more and have not taken apremilast before, you may be a fit.
This study compares two oral medications—methotrexate and apremilast—to see which works better for relieving itching in people with psoriasis. If you have psoriasis and bothersome itching, you may be able to join.
This study looks at how well two common plaque psoriasis medicines—deucravacitinib and apremilast—work in everyday care. It may help researchers understand which option performs better in real patients outside of a traditional drug trial.
This trial tests a new topical cream for people with mild or moderate plaque psoriasis. It aims to see if the cream can improve psoriasis patches on the skin.
This Phase 3 trial tests apremilast to treat active juvenile psoriatic arthritis (joint inflammation) in children and teens. You may be able to join if your child’s condition is active despite prior treatments or if they couldn’t tolerate them.
This trial tests a cream called roflumilast for people with plaque psoriasis on the body and nail psoriasis. It aims to see if the cream safely improves both skin and nails.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.